Figure 3.
Kinetin increases IKAP levels in transgenic mice. (A) Western blots of brain and liver tissues in TgFD1 transgenic mice following treatment with kinetin diet for a period of 30 days. Top and bottom panels show the blot probed with an IKAP antibody and β-tubulin antibody, respectively. Human brain and C57BL6 mouse liver tissues were used as positive (+) and negative (−) controls, respectively. (B) Bar charts show the densitometric analysis on western blots of brain and liver tissues after kinetin diet for a period of 30 days. White and black bars represent control and kinetin-fed mice, respectively. Error bars represent SEM (n= 3). Significant differences from control are represented by ** (P< 0.01); Student's t-test.